8-K filings / November 17, 2026
Artiva Biotherapeutics, Inc.: A change of officers or directors
Artiva Biotherapeutics, Inc. filed a current report (Form 8-K) with the SEC on November 17, 2026. It reports a change of officers or directors.
Item 5.02
Officers and directors
-
Leaves
Elizabeth Hougen, DirectorEffective November 11, 2026
From the filing
Source
“On November 11, 2026, Elizabeth Hougen notified the Company of her decision to resign from the board of directors (the “Board”) of the Company as a Class III Director, effective immediately.”
Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.